Enoxaparin Sodium Injection
Pricing Report NDC 63323-609-90

Latest NADAC: $14.89859 per ML · Effective Mar 22, 2023 · Est. package price $119.19 (8 ML)

Current Package Pricing Information

The latest wholesale acquisition cost for Enoxaparin Sodium (NDC 63323-609-90) is $14.89859 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Mar 22, 2023.

As a a human prescription drug provided by Fresenius Kabi Usa, Llc, this medication is distributed in a 10 CELLO PACK in 1 CARTON / 1 SYRINGE in 1 CELLO PACK (63323-609-01) / .8 mL in 1 SYRINGE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$14.89859
Per ML

Effective Date
Mar 22, 2023
Billable Units
8 ML
Estimated Package Price
$119.19
Data Status
As of Mar 29, 2023
C/I - Chain or Independent Pharmacy
Package NDC
Description
10 CELLO PACK in 1 CARTON / 1 SYRINGE in 1 CELLO PACK (63323-609-01) / .8 mL in 1 SYRINGE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2020, the NADAC wholesale price for (NDC ) has moved within a range of $13.98701 to $18.86342 per ML. Over this 2 years and 5 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$13.9870 - $18.8634
Market Volatility
34.86% Variance
Latest Trend
15.12%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Mar 22, 2023 $14.89859 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 22, 2023 $17.55304 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 18, 2023 $13.98701 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 21, 2022 $17.74597 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 23, 2022 $15.63684 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 19, 2022 $18.86342 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 21, 2022 $17.75083 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 17, 2022 $17.21135 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 20, 2022 $14.33118 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 22, 2022 $15.89638 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 18, 2022 $18.20484 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 20, 2022 $13.99000 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026